DUSI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 7.336
EU - Europa 6.409
AS - Asia 4.084
SA - Sud America 492
Continente sconosciuto - Info sul continente non disponibili 122
AF - Africa 92
OC - Oceania 17
Totale 18.552
Nazione #
US - Stati Uniti d'America 7.106
RU - Federazione Russa 2.018
SG - Singapore 1.517
CN - Cina 1.335
GB - Regno Unito 1.324
IT - Italia 1.136
BR - Brasile 406
DE - Germania 374
FI - Finlandia 328
HK - Hong Kong 317
VN - Vietnam 305
FR - Francia 293
SE - Svezia 285
IE - Irlanda 260
KR - Corea 139
CA - Canada 123
IN - India 88
UA - Ucraina 85
NL - Olanda 77
BD - Bangladesh 67
TR - Turchia 65
ES - Italia 53
JP - Giappone 53
ID - Indonesia 47
BE - Belgio 43
AR - Argentina 35
MX - Messico 34
AT - Austria 29
PL - Polonia 22
PK - Pakistan 21
NG - Nigeria 20
IQ - Iraq 19
AU - Australia 15
ZA - Sudafrica 15
CZ - Repubblica Ceca 14
EC - Ecuador 14
SV - El Salvador 13
CL - Cile 12
TH - Thailandia 12
MA - Marocco 11
AZ - Azerbaigian 10
CO - Colombia 10
CR - Costa Rica 10
PH - Filippine 10
PR - Porto Rico 10
UZ - Uzbekistan 10
HN - Honduras 8
MY - Malesia 8
PT - Portogallo 8
TG - Togo 8
JO - Giordania 7
LT - Lituania 7
RO - Romania 7
TT - Trinidad e Tobago 7
BJ - Benin 6
CH - Svizzera 6
EG - Egitto 6
GR - Grecia 6
JM - Giamaica 6
KZ - Kazakistan 6
CW - ???statistics.table.value.countryCode.CW??? 5
CY - Cipro 5
DZ - Algeria 5
IR - Iran 5
KE - Kenya 5
NI - Nicaragua 5
NP - Nepal 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
DK - Danimarca 4
GT - Guatemala 4
HU - Ungheria 4
LV - Lettonia 4
OM - Oman 4
PY - Paraguay 4
RS - Serbia 4
SA - Arabia Saudita 4
BO - Bolivia 3
EU - Europa 3
GP - Guadalupe 3
IL - Israele 3
QA - Qatar 3
SN - Senegal 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BS - Bahamas 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
KG - Kirghizistan 2
LB - Libano 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
Totale 18.417
Città #
Ashburn 1.090
Southend 1.040
Singapore 842
Moscow 660
San Jose 631
Jacksonville 621
Chandler 556
Dallas 385
Woodbridge 335
Ann Arbor 330
Hong Kong 302
Houston 301
Dublin 259
Verona 240
Beijing 226
Council Bluffs 190
The Dalles 189
Munich 171
Los Angeles 126
New York 118
Helsinki 96
Jinan 95
Wilmington 95
Lawrence 91
Princeton 91
Ho Chi Minh City 88
Shenyang 85
Milan 84
Rome 84
Nanjing 81
Hanoi 70
Buffalo 68
Santa Clara 63
Lancaster 57
São Paulo 57
Hebei 56
Tokyo 51
Boardman 50
Changsha 49
Tianjin 47
Turku 47
Toronto 43
Brussels 41
Nanchang 40
Zhengzhou 39
Redmond 37
Haikou 36
Columbus 34
Chicago 31
Seattle 31
Ningbo 30
Redondo Beach 30
Guangzhou 29
London 29
Taizhou 29
Denver 28
Jakarta 28
Orem 28
Hangzhou 27
Seoul 27
Vienna 27
Las Vegas 26
Montreal 26
Atlanta 24
Falls Church 24
Jiaxing 24
Frankfurt am Main 23
Taiyuan 23
Bologna 22
Boydton 22
Brooklyn 22
Phoenix 21
Annandale 20
Norwalk 19
Sindelfingen 19
Warsaw 19
Florence 17
Naples 17
Amsterdam 16
Chennai 16
San Francisco 16
Boston 15
Da Nang 15
Lanzhou 15
Washington 15
Philadelphia 14
Abuja 13
Auburn Hills 12
Belo Horizonte 12
Dhaka 12
Haiphong 12
Mexico City 12
Stockholm 12
Manchester 11
Baku 10
Dong Ket 10
Fairfield 10
Granada 10
Johannesburg 10
Lahore 10
Totale 11.407
Nome #
Miristilazione di proteine in monociti e macrofagi umani. Effetti dell'interferone-gamma (IFN-gamma) e del fattore di necrosi tumorale (TNF/Cachectin) 886
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 332
Avoiding undesired effects in the interaction of nanostructures with immune cells: the Role of Oxyresveratrol 291
Citrate-stabilized lanthanide-doped nanoparticles: brain penetration and interaction with immune cells and neurons 257
Decreased activity of liver glutathione peroxidase in human hepatocellular carcinoma 256
Luminescent porous silicon micro-particles as biocompatible and traceable drug delivery system 252
Multifunctional nanoprobes based on upconverting lanthanide doped CaF2: towards biocompatible materials for biomedical imaging 244
A 1.1-kb duplication in the p67phox gene causes chronic granulomatous disease 241
Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts 240
Activation of NADPH-dependent superoxide production in plasma membrane extracts of pig neutrophils by phosphatidic acid. 237
Capitolo 2 : Meccanismi di difesa 229
Beta-amyloid activates the O2- forming NADPH oxidase in microglia, monocytes and neutrophils. 228
ESAT-6 and HspX improve the effectiveness of BCG to induce human dendritic cells-dependent Th1 and NK cells activation 224
Fluoride can activate the respiratory burst independently of Ca2+, stimulation of phosphoinositide turnover and protein kinase C translocation in primed human neutrophils 219
Formation of inositol (1,4,5) trisphosphate and increase of cytosolic Ca2+ mediated by Fc receptors in human neutrophils 218
Lanthanidae doped CaF2 nanoparticles : biocompatible multifunctional materials for biomedical imaging 218
Lanthanide-doped CaF2 and SrF2 nanoparticles for biomedical applications: in vivo and in vitro experimental studies 217
Identification of a double mutation (D160V-K161E) in the p67phox gene of a Chronic Granulomatous Disease patient 216
G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms 215
Fibronectina plasmatica nelle epatopatie:correlazione con gli indici di protidosintesi 214
A possible role for MAP kinases and for a 75 kDa protein in the activation of NADPH oxidase 214
Interferon-gamma and tumor necrosis factor-alpha enhance p60src expression in human macrophages and myelomonocytic cell lines 209
Cytochrome b-245 reduction in neutrophils compared with the activation of NADPH oxidase 208
In human neutrophils the binding to immunocomplexes induces the tyrosine phosphorylation of Fc gamma RII but this phosphorylation is not an essential signal for Fc-mediated phagocytosis 207
ESAT-6 and HspX improve the effectiveness of BCG to induce human Dendritic Cells-dependent T cells and NK cells activation 206
TiO2 coating of luminescent porous silicon by ALD technique for biomedical applications 205
NADPH oxidase activity and zymosan uptake regulation in human dendritic cells 200
Mechanisms of NADPH oxidase expression in cultured monocytes 199
ESAT-6 and HspX improve the effectiveness of BCG to induce human Dendritic Cells-dependent T cells and NK cells activation 199
Targeted PLGA nanocarriers for brain drug delivery 198
Activation of NADPH oxidase of human neutrophils involves the phosphorylation and the translocation of cytosolic p67phox 197
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro 196
Oxyresveratrol Inhibits R848-Induced Pro-Inflammatory Mediators Release by Human Dendritic Cells Even When Embedded in PLGA Nanoparticles 191
Chronic granulomatous disease in an adult female with granulomatous cheilitis. Evidence for an X-linked pattern of inheritance with extreme lyonization 189
Fibronectina plasmatica nelle epatopatie: correlazione con gli indici di protidosintesi 188
TiO2-coated pSi microparticles for nanomedicine 188
Interferon alpha and gamma improve NADPH oxidase-mediated candida albicans killing by human dendritic cells: receptor mechanisms of NADPH oxidase regulation by yeasts 187
Nanoparticles in the brain parenchyma: a friendly relationship? 185
Measurement of NADPH oxidase activity in detergent lysates of human and mouse macrophage monolayers 184
ELA2 genotype-phenotype correlation to be expected in patients with severe congenital neutropenia 183
Effects of Mycobacterium tuberculosis on DC apoptosis, maturation and oxygen free radicals production 182
Inteferon-gamma induces gp91phox expression in human monocytes via protein kinase C-dependent phosphorylation of PU.1. 181
Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors 180
Interleukin-10 decreases tyrosine phosphorylation of discrete lipopolysaccharide-induced phosphoproteins in human granulocytes 178
Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications 177
Titanium dioxide coating of porous silicon microparticles towards nanomedicine applications 177
Pitfalls of flow cytometric analysis by dihydrorodamine-123 in the diagnosis of chronic granulomatous disease 176
Production of oxygen radicals in pathogen-activated dendritic cells 176
Dissociation between the activation of phosphoinositide turnover and of NADPH oxidase by f-MET-LEU-PHE (fMLP) in neutrophils depleted of Ca2+ and primed by subtreshold doses of phorbol 12, myristate 13, acetate (PMA) 175
Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, mannose receptor, and DC-SIGN 173
ESAT-6 and HspX improve the effectiveness of Bacille Calmette-Guerin to induce human dendritic cells-dependent T cells and natural killer cells activation. 171
Prostate Carcinoma Cells LNCaP and Glucan Cooperate inInduction of Cytokine Synthesis by Dendritic Cells: Effect onNatural Killer Cells and CD4+ Lymphocytes Activation 171
Transmembrane signaling pathways involved in phagocytosis and associated activation of NADPH oxidase mediated by Fc gamma Rs in human neutrophils 169
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis 166
Orange and blue luminescence emission to track functionalized porous silicon microparticles inside the cells of the human immune system 166
Prostate carcinoma cells LNCaP differentially regulate cytokine release in dectin 1- and Toll-like receptor- stimulated human monocyte-derived dendritic cells 164
The inclusion into PLGA nanoparticles enables a-bisabolol to efficiently inhibit the human dendritic cell proinflammatory activity 164
Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of cytokines produced by human dendritic cells and pathogen recognition receptors involved 163
Interferon-gamma activates human neutrophil oxygen metabolism and exocytosis 162
Mechanisms of expression of NADPH oxidase components in human cultured monocytes: role of cytokines and transcriptional regulators involved. 161
Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I 161
Studies on the nature and activation of O2- -forming NADPH oxidase of leukocytes. II. Relationships between phosphorylation of a component of the enzyme and oxidase activity 160
Mechanisms of NADPH oxidase assembly and regulation in human neutrophils 160
Toll receptor-mediated regulation of NADPH oxidase in human dendritic cells 159
Tyrosine phosphorylation and activation of NADPH oxidase in human neutrophils: a possible role for MAP kinases and for a 75 kDa protein 158
Prostate carcinoma cells LNCaP differentially regulate cytokine release in dectin-1 and Toll-like receptor-stimulated human monocyte-derived dendritic cells 156
Oxyresveratrol-Loaded PLGA Nanoparticles Inhibit Oxygen Free Radical Production by Human Monocytes: Role in Nanoparticle Biocompatibility 156
Effects of Magnetic Nanoparticles on the Functional Activity of Human Monocytes and Dendritic Cells 155
Studies on the NADPH oxidase of phagocytes. Production of a monoclonal antibody which blocks the enzymatic activity of pig neutrophil NADPH oxidase 154
Tyrosine phosphorylation of phospholipase C-gamma 2 is involved in the activation of phosphoinositide hydrolysis by Fc receptors in human neutrophils 153
The respiratory burst of phagocytes 153
The O2- forming system of phagocytes 150
Mechanisms of NADPH oxidase activation in human neutrophils: p67phox is required for the translocation of rac 1 but not of rac 2 from cytosol to the membranes 149
The free radical forming system of granulocytes and macrophages: further studies 149
NADPH oxidase of human dendritic cells: role in candida albicans killing and regulation by interferons, dectin-1 and cd206 146
Relationships between translocation and phosphorylation of p47phox and p67phox NADPH oxidase components 146
Proinflammatory effects of bare and pegylated ormosyl-, plga-, and suv-NPs on monocytes and PMNs and their modulation by f-MLP 145
The stimulation of human monocytes with interferon-gamma induces the phosphorylation of PU.1 and its binding to gp91phox promoter via activation of a classical protein kinase C 145
Triggering and regulation of the free radical production by phagocytes 144
Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components. 144
Genetic defect of phagocyte NADPH oxidase activity and activation. 143
TiO2-coated luminescent porous silicon micro-particles as a promising system for nanomedicine 141
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 140
Effects of Magnetic Nanoparticles on the Functional Activity of Human Monocytes and Dendritic Cells 138
Relationship between phosphorylation and translocation to the plasma membrane of p47phox and p67phox and activation of the NADPH oxidase in normal and Ca(2+)-depleted human neutrophils 138
Donor Cell Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: A Case Report and Literature Review 136
Tumor necrosis factor triggers redistribution to a Triton X-100-insoluble, cytoskeletal fraction of beta 2 integrins, NADPH oxidase components, tyrosine phosphorylated proteins, and the protein tyrosine kinase p58fgr in human neutrophils adherent to fibrinogen. 136
Mesoporous Silicon as a Potential Candidate for Nanotheranostics 136
Studies of NADPH oxidase composition and function by monoclonal antibodies 135
Tyrosine phosphorylation and subcellular redistribution of p125ras guanosine triphosphatase-activating protein in human neutrophils stimulated with FMLP. 124
Role of 55- and 75-kDa TNF receptors in the potentiation of Fc-mediated phagocytosis in human neutrophils 123
Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway 122
The neutrophil-activating protein (HP-NAP) of helicobacter pylori is a protective antigen and a major virulence factor. 122
Innate immunity defects in Hermansky-Pudlak type 2 syndrome 121
Mechanisms of stimulation of the respiratory burst by TNF-alfa in non adherent neutrophils: independency of lipidic transmembrane signaling and dependency on protein tyrosine phosphorylation and cytoskeleton. 119
Nicotinamide-Adenine Dinucleotide Phosphate Oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients. 116
Mechanisms of NADPH oxidase activation: translocation of p40phox, rac 1 and rac 2 from the cytosol to the membranes in human neutrophils lacking p47phox or p67phox. 113
Translocation of p190rho guanosine triphosphatase-activating protein from cytosol to the membrane in human neutrophils stimulated with different agonists. 111
Monocytes of patients with systemic sclerosis (scleroderma) spontaneously release in vitro increased amounts of superoxide anion 105
Porous silicon microparticles as efficient carriers for immunologic adjuvants 104
Totale 18.365
Categoria #
all - tutte 57.005
article - articoli 36.881
book - libri 0
conference - conferenze 17.496
curatela - curatele 0
other - altro 627
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.001
Totale 114.010


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022533 0 0 0 46 54 30 26 45 41 54 67 170
2022/20231.670 127 177 133 278 135 398 29 105 186 11 56 35
2023/20241.084 57 54 78 87 156 118 81 106 19 77 160 91
2024/20252.632 144 179 111 419 174 132 206 142 328 129 227 441
2025/20266.595 466 267 497 1.051 1.730 496 711 306 450 370 92 159
2026/20271.288 75 156 312 745 0 0 0 0 0 0 0 0
Totale 18.552